FIRM FIXED PRICENO SET ASIDE USED.

THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER - DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY

PIID: 75F40120P00519Solicitation ID: FDA_20-233-1229716
Signed Date: Jan 20, 2026Effective Date: Aug 17, 2020End Date: Closed on Mar 31, 2023
Award $
$203K
Vendor
THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
NAICS
112990
Signed Date
Jan 20, 2026

Key Details

Dollars Obligated
$202,649.54
Base & All Options
$-709,003.46
Awarding Sub-Agency
Food and Drug Administration
Product Service Code
R425 - SUPPORT- PROFESSIONAL: ENGINEERING/TECHNICAL
Extent Competed
COMPETED UNDER SAP
Number of Offers
1
Place of Performance
HOUSTON, TX, 770304017, CD-TX-09

Description

DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY

Context & Analysis

On Jan 20, 2026, Department of Health and Human Services obligated $202,649.54 to THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER for duration of pertussis immunity in baboons study. The award is classified under NAICS 112990 — ALL OTHER ANIMAL PRODUCTION and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in HOUSTON, TX. This award is one of several similar procurements from Department of Health and Human Services under NAICS 112990 — related awards are listed below.

Contractor Information

UEI: S3GMKS8ELA16
CAGE Code: 0KD38
Location: HOUSTON, TX
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related